MedPath

A small scale preliminary study aimed at assessing the effects of different quantity (normal, low and very low protein diet supplemented with essential keto amino acids) of protein intakes on kidney Disease progression and the impact of this intervention in Quality of life of patients

Not Applicable
Conditions
Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 2: N184- Chronic kidney disease, stage 4 (severe)Health Condition 3: N185- Chronic kidney disease, stage 5
Registration Number
CTRI/2020/06/025785
Lead Sponsor
Indian council of Medical research ICMR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed as CKD Stages 3, 4 and 5 not on dialysis based on the KDIGO 2012 guidelines

Exclusion Criteria

1. Any acute medical illness

2. Unstable renal function

3. Neurological illness, which causes hindrance in daily routine

4. Acute Kidney Injury

5. Renal Transplant Recipients

6. Malignancy

7. Pregnancy

8. Steroids Intake

9. Hypercalcemia (serum Calcium >10.5 mg/dl)

10. Alcoholics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect on different protein diet on prevention of CKD progression, delaying dialysis initiation, effect on nutrition, Quality of lifeTimepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
Cost effectiveness of providing ketoanalogues (with VLPD) in relation to delay in initiation of dialysisTimepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath